Notice of Vitamin D Standardization Program (VDSP) Symposium: Tools To Improve Laboratory Measurement, 63999 [2013-25277]

Download as PDF Federal Register / Vol. 78, No. 207 / Friday, October 25, 2013 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; Alzheimer’s Disease Sequencing Project. Date: October 29, 2013. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: DoubleTree by Hilton Hotel, 8120 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Elaine Lewis, Ph.D., Scientific Review Officer, Scientific Review Branch, National Institute on Aging, Gateway Building, Suite 2C212, MSC–9205, 7201 Wisconsin Avenue, Bethesda, MD 20892, 301–402–7707, elainelewis@nia.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: October 21, 2013. Melanie J. Gray, Program Analyst, Office of Federal Advisory Committee Policy. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIH Support for Conferences and Scientific Meetings (R13). Date: November 18–22, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Virtual Meeting). Contact Person: Kelly Y. Poe, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700–B Rockledge Drive, MDS–7616, Bethesda, MD 20892–7616, 301–451–2639, poeky@ niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Mechanisms of Cellular Immunity in the Female Reproductive Tract. Date: November 20, 2013. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817, (Telephone Conference Call). Contact Person: Lakshmi Ramachandra, Ph.D., Scientific Review Officer, Scientific Review Program, DEA/NIAID/NIH/DHHS, 6700–B Rockledge Drive, MSC–7616, Bethesda, MD 20892–7616, 301–496–2550, Ramachandral@niaid.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) [FR Doc. 2013–25035 Filed 10–24–13; 8:45 am] Dated: October 21, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. BILLING CODE 4140–01–P [FR Doc. 2013–25031 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES emcdonald on DSK67QTVN1PROD with NOTICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections VerDate Mar<15>2010 17:55 Oct 24, 2013 Jkt 232001 National Institutes of Health Notice of Vitamin D Standardization Program (VDSP) Symposium: Tools To Improve Laboratory Measurement The National Institutes of Health, Office of Dietary Supplements (ODS), and the National Institute of Standards and Technology (NIST), are sponsoring a one-day symposium on November 14, 2013, to present SUMMARY: PO 00000 Frm 00041 Fmt 4703 Sfmt 9990 63999 information about the Vitamin D Standardization Program (VDSP) to those with an interest in the effort to standardize vitamin D measurement. These groups include commercial assay manufacturers; commercial, clinical, and research laboratory personnel; vitamin D researchers; and members of professional societies with clinical and public health interest in vitamin D. November 14, 2013, 8:30 a.m. to 5:30 p.m. (Eastern Time). DATES: NIST, 100 Bureau Drive, Green Auditorium, Gaithersburg, MD 20899–1070. The NIST campus is a highly secured area. Because of this, you are required to register in advance and must present a current governmentissued identification card with photo when entering the facility. The Web address for registration is https://eventssupport.com/events/VDSP_Symposium_ 2013. ADDRESSES: Ms. Cindy Rooney, ODS, National Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892–7523; email: rooneyc@mail.nih.gov. FOR FURTHER INFORMATION CONTACT: The ODS established the VDSP in November 2010 in an effort to standardize the laboratory measurement of vitamin D status worldwide. Standardization is essential to improve the detection, evaluation, and treatment of vitamin D deficiency and insufficiency by making measurements of serum total 25hydroxyvitamin D [25(OH)D] accurate and comparable over time, location, and laboratory procedure. The symposium on November 14 will (1) Describe the VDSP; (2) present data from the VDSP inter-laboratory comparison and commutability studies demonstrating its effectiveness; (3) demonstrate how tools developed through the VDSP can be used to improve the standardization of vitamin D measurement in the United States and around the world; and (4) solicit feedback from symposium participants on how the VDSP can be improved to meet the needs of participants. All participants must register at https:// events-support.com/events/VDSP_ Symposium_2013. SUPPLEMENTARY INFORMATION: Dated: October 21, 2013. Lawrence A. Tabak, Deputy Director, NIH. [FR Doc. 2013–25277 Filed 10–24–13; 8:45 am] BILLING CODE 4140–01–P E:\FR\FM\25OCN1.SGM 25OCN1

Agencies

[Federal Register Volume 78, Number 207 (Friday, October 25, 2013)]
[Notices]
[Page 63999]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-25277]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Vitamin D Standardization Program (VDSP) Symposium: 
Tools To Improve Laboratory Measurement

SUMMARY: The National Institutes of Health, Office of Dietary 
Supplements (ODS), and the National Institute of Standards and 
Technology (NIST), are sponsoring a one-day symposium on November 14, 
2013, to present information about the Vitamin D Standardization 
Program (VDSP) to those with an interest in the effort to standardize 
vitamin D measurement. These groups include commercial assay 
manufacturers; commercial, clinical, and research laboratory personnel; 
vitamin D researchers; and members of professional societies with 
clinical and public health interest in vitamin D.

DATES: November 14, 2013, 8:30 a.m. to 5:30 p.m. (Eastern Time).

ADDRESSES: NIST, 100 Bureau Drive, Green Auditorium, Gaithersburg, MD 
20899-1070. The NIST campus is a highly secured area. Because of this, 
you are required to register in advance and must present a current 
government-issued identification card with photo when entering the 
facility. The Web address for registration is https://events-support.com/events/VDSP_Symposium_2013.

FOR FURTHER INFORMATION CONTACT: Ms. Cindy Rooney, ODS, National 
Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 
20892-7523; email: rooneyc@mail.nih.gov.

SUPPLEMENTARY INFORMATION: The ODS established the VDSP in November 
2010 in an effort to standardize the laboratory measurement of vitamin 
D status worldwide. Standardization is essential to improve the 
detection, evaluation, and treatment of vitamin D deficiency and 
insufficiency by making measurements of serum total 25-hydroxyvitamin D 
[25(OH)D] accurate and comparable over time, location, and laboratory 
procedure.
    The symposium on November 14 will (1) Describe the VDSP; (2) 
present data from the VDSP inter-laboratory comparison and 
commutability studies demonstrating its effectiveness; (3) demonstrate 
how tools developed through the VDSP can be used to improve the 
standardization of vitamin D measurement in the United States and 
around the world; and (4) solicit feedback from symposium participants 
on how the VDSP can be improved to meet the needs of participants. All 
participants must register at https://events-support.com/events/VDSP_Symposium_2013.

    Dated: October 21, 2013.
Lawrence A. Tabak,
Deputy Director, NIH.
[FR Doc. 2013-25277 Filed 10-24-13; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.